https://www.prnewswire.com/news-releases/clover-biopharmaceuticals-and-dynavax-announce-first-participants-dosed-in-spectra-a-global-phase-23-clinical-trial-for-adjuvanted-s-trimer-covid-19-vaccine-candidate-301254587.html?tc=eml_cleartime
/PRNewswire/ -- Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company developing transformative biologics such as vaccines and...
clover biopharmaceuticalsannouncefirstparticipantsdosed
https://cloverbiopharma.com/
Our mission is to leverage our Trimer-Tag technology and in-house manufacturing capabilities for the discovery, development and delivery of innovative and...
clover biopharmaceuticals
https://www.pharmaceutical-technology.com/news/clover-biopharmaceuticals-cepi-funds/
The CEPI has signed an agreement with Clover Biopharmaceuticals Australia to support the development of a Covid-19 vaccine candidate.
clover biopharmaceuticalsgetscepifundingcovid